19 . 04 .2023
Press release
Augmented reality: patient experience trumps misconceptions around injectables
30 . 03 .2023
Press release
AMWC 2023: Data from Sculptra® Cheek Wrinkle and Alluzience® Star Studies reinforce strength of Galderma’s broad aesthetic portfolio
22 . 03 .2023
Press release
Galderma launches FACE by Galderma™, a cutting-edge aesthetic visualization tool that simulates injectable treatment results in real-time
18 . 03 .2023
Press release
AAD 2023: Late-Breaking Phase III results demonstrate nemolizumab’s significant impact on prurigo nodularis
17 . 03 .2023
News story
AAD 2023: Extensive updates from Galderma’s broad and innovative portfolio through posters and presentation sessions
15 . 03 .2023
Press release
Cetaphil Celebrates Global Initiative Highlighting Sensitive Skin with a Month of Skin Science Education
13 . 03 .2023
Press release
Galderma delivers strong FY 2022 growth driven by innovation and commercial performance
02 . 03 .2023
Press release
Cetaphil® unveils digital AI skin analysis tool to empower and educate users with sensitive skin